Drugs & Targets FDA approves Ventana ALK (D5F3) CDx companion diagnostic assay for Xalkori June 19, 2015Vol.41 No.24
Drugs & Targets Janssen initiates rolling submission for daratumumab in multiple myeloma June 12, 2015Vol.41 No.23
Drugs & Targets FDA Grants Orphan Designation for Reolysin in Malignant Glioma June 01, 2015Vol.38 No.05